UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Community-Based, Randomized Trial of Ezetimibe Added to Statin Therapy to Attain NCEP ATP III Goals for LDL Cholesterol in Hypercholesterolemic Patients: The Ezetimibe Add-On to Statin for Effectiveness (EASE) Trial

Mayo Clinic proceedings, 2005-05, Vol.80 (5), p.587-595

2005

Volltextzugriff (PDF)

Effectiveness of Ezetimibe Added to Ongoing Statin Therapy in Modifying Lipid Profiles and Low-Density Lipoprotein Cholesterol Goal Attainment in Patients of Different Races and Ethnicities: A Substudy of the Ezetimibe Add-On to Statin for Effectiveness Trial

Mayo Clinic proceedings, 2006-09, Vol.81 (9), p.1177-1185

2006

Volltextzugriff (PDF)

Once-weekly alendronate 70 mg and raloxifene 60 mg daily in the treatment of postmenopausal osteoporosis

Menopause (New York, N.Y.), 2004-07, Vol.11 (4), p.405-415

2004

Volltextzugriff (PDF)

Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: The Vytorin Versus Atorvastatin (VYVA) Study

The American heart journal, 2005-03, Vol.149 (3), p.464-473

2005

Volltextzugriff (PDF)

Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial

JAMA : the journal of the American Medical Association, 2004-09, Vol.292 (11), p.1307

2004

Volltextzugriff (PDF)

Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial)

The American journal of cardiology, 2005-02, Vol.95 (4), p.462-468

2005

Volltextzugriff (PDF)

Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia

The American journal of cardiology, 2004-06, Vol.93 (12), p.1487-1494

2004

Volltextzugriff (PDF)

Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: Subanalyses of data from a randomized, double-blind, placebo-controlled trial

The American journal of geriatric pharmacotherapy, 2005-12, Vol.3 (4), p.218-228

2005

Volltextzugriff (PDF)

Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial

JAMA : the journal of the American Medical Association, 2004-07, Vol.292 (1), p.55

2004

Volltextzugriff (PDF)

Developing Drugs for Rare Diseases: Regulatory Strategies and Considerations

Drug Development for Rare Diseases, 2023, p.17-33

1, 2023

Volltextzugriff (PDF)

Sequence variation in NPC1L1 and association with improved LDL-cholesterol lowering in response to ezetimibe treatment

Genomics (San Diego, Calif.), 2005-12, Vol.86 (6), p.648-656

2005

Volltextzugriff (PDF)

Lipid altering-efficacy of ezetimibe co-administered with simvastatin compared with rosuvastatin: a meta-analysis of pooled data from 14 clinical trials

Current medical research and opinion, 2005-07, Vol.21 (7), p.1123-1130

2005

Volltextzugriff (PDF)

The rechallenge of patients who previously discontinued alendronate due to upper gastrointestinal symptoms

The American journal of gastroenterology, 2000-09, Vol.95 (9), p.2457-2457

2000

Volltextzugriff (PDF)

Tolerability of Once-Weekly Alendronate in Patients With Osteoporosis: A Randomized, Double-Blind, Placebo-Controlled Study

Mayo Clinic proceedings, 2002-10, Vol.77 (10), p.1044-1052

2002

Volltextzugriff (PDF)

Effect on high-density lipoprotein cholesterol of maximum dose simvastatin and atorvastatin in patients with hypercholesterolemia: Results of the Comparative HDL Efficacy and Safety Study (CHESS)

The American heart journal, 2003-11, Vol.146 (5), p.862-869

2003

Volltextzugriff (PDF)

Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: results from the A phase of the A-to-Z trial

European heart journal, 2004-10, Vol.25 (19), p.1688-1694

2004

Volltextzugriff (PDF)

Dyslipidemia in Patients with Type 2 Diabetes. Relationships between Lipids, Kidney Disease and Cardiovascular Disease

Clinical chemistry and laboratory medicine, 2003-09, Vol.41 (9), p.1174-1181

2003

Volltextzugriff (PDF)

Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60 years with male pattern hair loss

EJD. European journal of dermatology, 2003-03, Vol.13 (2), p.150-160

2003

Volltextzugriff (PDF)

Ezetimibe/Simvastatin Versus Atorvastatin for Patients Who Have Diabetes Mellitus and Hypercholesterolemia

Diabetes (New York, N.Y.), 2005-06, Vol.54, p.A235

2005

Volltextzugriff (PDF)

1084-176 Efficacy of ezetimibe coadministered with simvastatin versus atorvastatin in patients with hypercholesterolemia

Journal of the American College of Cardiology, 2004-03, Vol.43 (5), p.A480-A481

2004

Volltextzugriff (PDF)

Effectiveness of simvastatin therapy in raising HDL-C in patients with type 2 diabetes and low HDL-C

Current medical research and opinion, 2004-07, Vol.20 (7), p.1087-1094

2004

Volltextzugriff (PDF)

Hyperfiltration in African-American patients with type 2 diabetes. Cross-sectional and longitudinal data

Diabetes care, 1998-12, Vol.21 (12), p.2129-2134

1998

Volltextzugriff (PDF)

Dyslipidemia in patients with type 2 diabetes. Relationships between lipids, kidney disease and cardiovascular disease: Diabetes mellitus

Clinical chemistry and laboratory medicine, 2003, Vol.41 (9), p.1174-1181

2003

Volltextzugriff (PDF)

861-2 Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin, and an early conservation initial management strategy: Results from the A phase of the A to Z trial

Journal of the American College of Cardiology, 2004-03, Vol.43 (5), p.A302-A302

2004

Volltextzugriff (PDF)

The rechallenge of patients who previously discontinued alendronate due to upper gastrointestinal symptoms

The American journal of gastroenterology, 2000, Vol.95 (9), p.2457-2457

2000

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieClinical Therapeutics

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(23)

Publikationsform

Sprache

Englisch
(33)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Humans
(23)
Life Sciences & Biomedicine
(19)
Science & Technology
(19)
Biological And Medical Sciences
(16)
Female
(16)
Male
(16)
Medical Sciences
(15)
Middle Aged
(15)
Double-Blind Method
(11)
Aged
(9)
Drug Therapy, Combination
(9)
Treatment Outcome
(9)
Adult
(8)
Ezetimibe
(8)
General & Internal Medicine
(8)
Medicine, General & Internal
(8)
Cardiology. Vascular System
(7)
Hypercholesterolemia - Drug Therapy
(6)
Simvastatin - Administration & Dosage
(6)
Cholesterol, Ldl - Blood
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Community-Based, Randomized Trial of Ezetimibe Added to Statin Therapy to Attain NCEP ATP III Goals for LDL Cholesterol in Hypercholesterolemic Patients: The Ezetimibe Add-On to Statin for Effectiveness (EASE) Trial

Effectiveness of Ezetimibe Added to Ongoing Statin Therapy in Modifying Lipid Profiles and Low-Density Lipoprotein Cholesterol Goal Attainment in Patients of Different Races and Ethnicities: A Substudy of the Ezetimibe Add-On to Statin for Effectiveness Trial

Once-weekly alendronate 70 mg and raloxifene 60 mg daily in the treatment of postmenopausal osteoporosis

Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: The Vytorin Versus Atorvastatin (VYVA) Study

Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial

Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial)

Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia

Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: Subanalyses of data from a randomized, double-blind, placebo-controlled trial

Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial

Developing Drugs for Rare Diseases: Regulatory Strategies and Considerations

Sequence variation in NPC1L1 and association with improved LDL-cholesterol lowering in response to ezetimibe treatment

Lipid altering-efficacy of ezetimibe co-administered with simvastatin compared with rosuvastatin: a meta-analysis of pooled data from 14 clinical trials

The rechallenge of patients who previously discontinued alendronate due to upper gastrointestinal symptoms

Tolerability of Once-Weekly Alendronate in Patients With Osteoporosis: A Randomized, Double-Blind, Placebo-Controlled Study

Effect on high-density lipoprotein cholesterol of maximum dose simvastatin and atorvastatin in patients with hypercholesterolemia: Results of the Comparative HDL Efficacy and Safety Study (CHESS)

Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: results from the A phase of the A-to-Z trial

Dyslipidemia in Patients with Type 2 Diabetes. Relationships between Lipids, Kidney Disease and Cardiovascular Disease

Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60 years with male pattern hair loss

Ezetimibe/Simvastatin Versus Atorvastatin for Patients Who Have Diabetes Mellitus and Hypercholesterolemia

1084-176 Efficacy of ezetimibe coadministered with simvastatin versus atorvastatin in patients with hypercholesterolemia

Effectiveness of simvastatin therapy in raising HDL-C in patients with type 2 diabetes and low HDL-C

Hyperfiltration in African-American patients with type 2 diabetes. Cross-sectional and longitudinal data

Dyslipidemia in patients with type 2 diabetes. Relationships between lipids, kidney disease and cardiovascular disease: Diabetes mellitus

861-2 Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin, and an early conservation initial management strategy: Results from the A phase of the A to Z trial

The rechallenge of patients who previously discontinued alendronate due to upper gastrointestinal symptoms

Aktive Filter

Suchergebnisse filtern